Filed: 2/14/2025ACC: 0001964437-25-000003
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 24 equity positions with a total reported market value of $255.37M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
24
Positions
$255.37M
Total AUM (reported)
12.96M
Total Shares
Allocation by class
COM$158.62M62.1%
SPONSORED ADR$39.54M15.5%
CLASS A ORD$18.74M7.3%
COM NEW$16.39M6.4%
CL A$8.39M3.3%
SPONSORED ADS$4.78M1.9%
COM CL A$3.61M1.4%
Portfolio Concentration
Top 3$78.43M30.7%
4–10$104.29M40.8%
11–25$72.65M28.4%
Top 3 weight
30.7%
Top 10 weight
71.6%
Voting Authority Distribution
Total shares with voting rights: 12.96M
Sole
Full voting authority
12.96M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole24
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings24
Rows:
DISC MEDICINE INC
SOLEShares509.41K
TypeSH
Market value$32.30M
12.65%
Sole
509.41K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares198.98K
TypeSH
Market value$27.39M
10.73%
Sole
198.98K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares346.11K
TypeSH
Market value$18.74M
7.34%
Sole
346.11K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares593.26K
TypeSH
Market value$17.01M
6.66%
Sole
593.26K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares204.28K
TypeSH
Market value$16.72M
6.55%
Sole
204.28K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares348.36K
TypeSH
Market value$16.39M
6.42%
Sole
348.36K
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares1.01M
TypeSH
Market value$14.53M
5.69%
Sole
1.01M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares1.06M
TypeSH
Market value$13.92M
5.45%
Sole
1.06M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares988.53K
TypeSH
Market value$13.07M
5.12%
Sole
988.53K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares322.47K
TypeSH
Market value$12.64M
4.95%
Sole
322.47K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares19.75K
TypeSH
Market value$12.15M
4.76%
Sole
19.75K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.50M
TypeSH
Market value$11.69M
4.58%
Sole
1.50M
Shared
0.00
None
0.00
MERUS N V
SOLEShares234.64K
TypeSH
Market value$9.87M
3.86%
Sole
234.64K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares573.02K
TypeSH
Market value$8.39M
3.29%
Sole
573.02K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares653.07K
TypeSH
Market value$4.78M
1.87%
Sole
653.07K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares556.49K
TypeSH
Market value$4.71M
1.85%
Sole
556.49K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.37M
TypeSH
Market value$3.81M
1.49%
Sole
1.37M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares814.53K
TypeSH
Market value$3.61M
1.41%
Sole
814.53K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares889.07K
TypeSH
Market value$3.36M
1.32%
Sole
889.07K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares59.13K
TypeSH
Market value$3.02M
1.18%
Sole
59.13K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares395.02K
TypeSH
Market value$2.72M
1.06%
Sole
395.02K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares100K
TypeSH
Market value$2.57M
1.01%
Sole
100K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares191.46K
TypeSH
Market value$1.64M
0.64%
Sole
191.46K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares18K
TypeSH
Market value$331.7K
0.13%
Sole
18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DISC MEDICINE INCSOLE | COM | 509.41K | SH | $32.30M 12.65% | 509.41K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 198.98K | SH | $27.39M 10.73% | 198.98K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 346.11K | SH | $18.74M 7.34% | 346.11K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 593.26K | SH | $17.01M 6.66% | 593.26K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 204.28K | SH | $16.72M 6.55% | 204.28K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 348.36K | SH | $16.39M 6.42% | 348.36K | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 1.01M | SH | $14.53M 5.69% | 1.01M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 1.06M | SH | $13.92M 5.45% | 1.06M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 988.53K | SH | $13.07M 5.12% | 988.53K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 322.47K | SH | $12.64M 4.95% | 322.47K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 19.75K | SH | $12.15M 4.76% | 19.75K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.50M | SH | $11.69M 4.58% | 1.50M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 234.64K | SH | $9.87M 3.86% | 234.64K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 573.02K | SH | $8.39M 3.29% | 573.02K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 653.07K | SH | $4.78M 1.87% | 653.07K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 556.49K | SH | $4.71M 1.85% | 556.49K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.37M | SH | $3.81M 1.49% | 1.37M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 814.53K | SH | $3.61M 1.41% | 814.53K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 889.07K | SH | $3.36M 1.32% | 889.07K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 59.13K | SH | $3.02M 1.18% | 59.13K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 395.02K | SH | $2.72M 1.06% | 395.02K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 100K | SH | $2.57M 1.01% | 100K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 191.46K | SH | $1.64M 0.64% | 191.46K | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 18K | SH | $331.7K 0.13% | 18K | 0.00 | 0.00 |